Enveric Biosciences, Inc. (ENVB) insider trading

By person

28 insiders · 59 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Devanur Giri

10% owner

$49.88K (1)

$887.95K (2)

−$838.07K

1,761,989

$3.77M

−19.1%

Eberwein Jeffrey E.

10% owner

$609.63K (18)

—

+$609.63K

1,210,752

$2.59M

−23.4%

Rai Dhruwa N

Director

$598.53K (1)

—

+$598.53K

1,164,713

$2.49M

+134.5%

Lokesh Sikaria Trust Dated 12/14/2012 entity

10% owner

—

$29.55K (9)

−$29.55K

3,900,000

$8.35M

−2.5%

Sikaria Chanda

10% owner

—

$29.55K (9)

−$29.55K

1,650,000

$3.53M

−5.7%

Sikaria Family 2008 Revocable Trust Dated 02/28/2008 entity

10% owner

—

$29.55K (9)

−$29.55K

3,900,000

$8.35M

−2.5%

Sikaria Lokesh

10% owner

—

$29.55K (9)

−$29.55K

1,650,000

$3.53M

−5.7%

PASQUALONE FRANK

Director

$2.14K (1)

—

+$2.14K

26,423

$56.55K

—

Kelton Brent

Chief Executive Officer

—

1,079,953

$2.31M

+13,114%

Tucker Joseph Edward

Chief Executive Officer

—

962,562

$2.06M

—

Hagel Jillian Marie

Vice President of Innovation

—

567,404

$1.21M

—

Facchini Peter J.

Chief Innovation Officer

—

559,357

$1.20M

—

Coveney Kevin Michael

Chief Financial Officer

—

180,746

$386.80K

—

Langer Arthur M

Director

—

84,923

$181.74K

+86.1%

Rosenberg Robert Alan

Director

—

55,125

$117.97K

+34.8%

Kanubaddi Avani

President and COO

—

48,346

$103.46K

+26.1%

Angelis Dimitrios

Director

—

40,990

$87.72K

—

Pearse Robert G.

Director

—

40,473

$86.61K

—

Schabacker Marcus

Director

—

26,418

$56.53K

—

Kegler George A.

Director

—

26,418

$56.53K

—

WEBB MICHAEL D

Director

—

26,416

$56.53K

—

DeWitt Sheila

Director

—

26,306

$56.29K

—

Van Buiten John

Chief Financial Officer

—

25,000

$53.50K

—

Balakrishnan Venkatraman

Director

—

16,948

$36.27K

—

Mayer Solomon

Director

—

15,957

$34.15K

—

LUCI DAVID P

Director

—

2,430

$5.20K

0.0%

LIND DOUGLAS

Director

—

2,265

$4.85K

—

Shawah Robert G.

Director

—

400

$856.00

0.0%

No percentages here. This company's share count has moved by a factor of 16.7 over the window, from 596,978 to 9,944,920 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Enveric Biosciences, Inc.

By person

Individual transactions

What was left out